Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-25

Clinical Trial Update: Effects of Proteins Fraction Derived From Milk on Osteoporosis Prevention [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a milk-derived protein fraction for osteoporosis prevention has completed, with no efficacy results provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milk-derived protein fraction

Snippet

Sponsor: Soredab | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED